摘要
目的探讨阿莫西林克拉维酸钾联合阿奇霉素治疗小儿肺炎的临床疗效。方法将我院收治的96例肺炎患儿随机分为对照组(阿莫西林克拉维酸钾治疗)和试验组(阿莫西林克拉维酸钾+阿奇霉素治疗),各48例。比较两组患儿的治疗效果。结果试验组临床总有效率(93.75%)高于对照组(81.25%)(P<0.05);试验组发热消退时间(2.35±0.89)d、肺啰音消失时间(4.41±1.54)d、咳嗽消退时间(5.05±1.58)d及住院时间(6.84±2.22)d均短于对照组的(4.25±1.11)d、(7.35±2.33)d、(9.08±1.86)d、(12.24±2.42)d(P<0.05);试验组不良反应总发生率(6.25%)低于对照组(27.08%)(P<0.05)。结论阿莫西林克拉维酸钾联合阿奇霉素治疗小儿肺炎安全可靠。
Objective To investigate the clinical effect of amoxicillin potassium clavulanate potassium and azithromycin in the treatment of infantile pneumonia.Methods Ninety-six cases of children with pneumonia in our hospital were randomly divided into control group(received amoxicillin potassium clavulanate potassium treatment)and experimental group(received amoxicillin potassium clavulanate potassium and azithromycin treatment),with 48 cases in each group.The therapeutic effects of the two groups were compared.Results The total effective rate of the experimental group(93.75%)was higher than 81.25%of the control group(P<0.05).The time of fever extinction[(2.35±0.89)d],the time of pulmonary rales disappeared[(4.41±1.54)d],the time of cough subsiding(5.05±1.58)d]and hospitalization time[(6.84±2.22)d]of the experimental group were all shorter than(4.25±1.11)d,(7.35±2.33)d,(9.08±1.86)d and(12.24±2.42)d of the control group(P<0.05);the total incidence of adverse reactions in the experimental group was 6.25%,which was lower than 27.08%in the control group(P<0.05).Conclusion Amoxicillin potassiumclavulanate potassiumand azithromycin on pneumonia in children is safe and reliable.
作者
胡亚芳
HU Yafang(Traditional Chinese Medicine Hospital of Long County,Baoji 721200,China)
出处
《临床医学研究与实践》
2018年第1期98-99,共2页
Clinical Research and Practice
关键词
小儿肺炎
阿奇霉素
阿莫西林克拉维酸钾
infantile pneumonia
azithromycin
amoxicillin potassium clavulanate potassium
作者简介
胡亚芳(1978-),女,汉族,陕西陇县人,主治医师,学士。研究方向:儿科临床
